MPM
AMED

Meritage Portfolio Management’s Amedisys AMED Stock Holding History

Meritage Portfolio Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,950
Closed -$12.6M – 285
2020
Q4 		$12.6M Buy
42,950
+671
+2% +$172K 0.93% 25
2020
Q3 		$10M Sell
42,279
-74
-0.2% -$16.8K 0.89% 25
2020
Q2 		$8.41M Buy
42,353
+1,639
+4% +$306K 0.81% 29
2020
Q1 		$7.47M Sell
40,714
-2,612
-6% -$465K 1.01% 24
2019
Q4 		$7.23M Buy
43,326
+330
+0.8% +$49.1K 0.64% 41
2019
Q3 		$5.63M Buy
42,996
+1,445
+3% +$188K 0.53% 48
2019
Q2 		$5.04M Buy
41,551
+485
+1% +$57.6K 0.51% 59
2019
Q1 		$5.06M Sell
41,066
-298
-0.7% -$37.4K 0.51% 71
2018
Q4 		$4.84M Buy
+41,364
New +$4.88M 0.55% 61

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Meritage Portfolio Management's AMED Position: Q1 2021 in Review

Meritage Portfolio Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 42,950 shares — an estimated $12.6M sold.

Meritage Portfolio Management first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $12.6M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Meritage Portfolio Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Meritage Portfolio Management sold 42,950 Amedisys shares in Q1 2021, an estimated $12.6M.
  • Meritage Portfolio Management first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • Meritage Portfolio Management's Amedisys position peaked at $12.6M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Meritage Portfolio Management's 13F filing for Q1 2021, filed 27 Apr 2021.